Ripertamab
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Ripertamab, covering 2025-01-24 to 2026-02-05. Get the full timeline:
Most recent: Clinical Trial Update: Study of Ripertamab in Children With Frequent Relapses or Steroid-Dependent Nephrotic Syndrome [NA]